Suchergebnis | Hamburg Open Science

Facetten

17 Einträge gefunden

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
2023 - Forschungsinformationssystem des UKE - frei zugänglich
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy
2022 - Forschungsinformationssystem des UKE - frei zugänglich
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status
2021 - Forschungsinformationssystem des UKE - frei zugänglich
Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial
2020 - Forschungsinformationssystem des UKE
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial
2018 - Forschungsinformationssystem des UKE - frei zugänglich
Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer
2015 - Forschungsinformationssystem des UKE
Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers
2015 - Forschungsinformationssystem des UKE
Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
2014 - Forschungsinformationssystem des UKE - frei zugänglich
Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer
2014 - Forschungsinformationssystem des UKE - frei zugänglich
Prognostic relevance of glycosylation-associated genes in breast cancer
2014 - Forschungsinformationssystem des UKE
Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer
2013 - Forschungsinformationssystem des UKE
Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
2013 - Forschungsinformationssystem des UKE
Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers
2013 - Forschungsinformationssystem des UKE
Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.
2012 - Forschungsinformationssystem des UKE
Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
2011 - Forschungsinformationssystem des UKE
Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.
2011 - Forschungsinformationssystem des UKE - frei zugänglich
Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.
2009 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients

EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy

DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification status

Cardiotoxicity and Cardiovascular Biomarkers in Patients With Breast Cancer:Data From the GeparOcto-GBG 84 Trial

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer

Genomic predictor of residual risk of recurrence after adjuvant chemotherapy and endocrine therapy in high risk estrogen receptor-positive breast cancers

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer

Control of dataset bias in combined Affymetrix cohorts of triple negative breast cancer

Prognostic relevance of glycosylation-associated genes in breast cancer

Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Androgen receptor expression is a predictive marker in chemotherapy-treated patients with endocrine receptor-positive primary breast cancers

Melanoma antigen family A identified by the bimodality index defines a subset of triple negative breast cancers as candidates for immune response augmentation.

Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.

Homogeneous datasets of triple negative breast cancers enable the identification of novel prognostic and predictive signatures.

Loss of Plexin B1 is highly prognostic in low proliferating ER positive breast cancers--results of a large scale microarray analysis.